JessicaDianeSt. LaurentMD

Gynecologic Oncology

Physician

Dr. St. Laurent is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Brigham and Women's Hospital
Dana Farber Cancer Institute
Boston, MA 02115

Brigham and Women’s HospitalFellowship, Gynecologic Oncology, 2020 - 2023
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2016 - 2020
Tufts University School of MedicineClass of 2015

PubMed

3 citations
Successful treatment of stage IVB ovarian carcinosarcoma with PARP Inhibitor: A case report.
Jessica D St Laurent, Mary Kathryn Abel, Joyce Liu, Bradley J Quade, Michelle R Davis
Gynecologic Oncology Reports. 2024-02-01
9 citations
Treatment Approaches for Platinum-Resistant Ovarian Cancer.
Jessica St Laurent, Joyce F Liu
Journal of Clinical Oncology. 2024-01-10
1 citations
Non-invasive DNA methylation-based testing for the diagnosis of endometrial cancer.
Jessica St Laurent, Kevin M Elias
The Lancet. Oncology. 2023-12-01

Journal Articles

Human breast progenitor cell numbers are regulated by WNT and TBX3
Arendt LM, St Laurent J, Wronski A, Caballero S, Lyle SR, Naber SP, Kuperwasser C, PLoS One, 10/28/2014
Epoxide-mediated CifR repression of cif gene expression utilizes two binding sites in Pseudomonas aeruginosa
Ballok AE, Bahl CD, Dolben EL, Lindsay AK, St Laurent JD, Hogan DA, Madden DR, O'Toole GA., J Bacteriol, 10/1/2012